GALT
Galectin Therapeutics Inc
4.00$
-2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.5% | 98.3% | 98.3% | 98.7% | 98.9% | 98.6% | 97.4% | 98.9% | 98.9% | 99.5% | 99.6% | 98.9% | |
| 91.9% | 91.0% | 91.0% | 92.6% | 93.4% | 86.4% | 78.0% | 88.3% | 89.6% | 90.7% | 89.5% | 89.5% | |
| 91.9% | 91.0% | 91.0% | 92.6% | 93.4% | 86.4% | 78.0% | 88.3% | 89.6% | 90.7% | 89.5% | 89.5% | |
| 329.5% | 313.6% | 374.6% | 397.0% | 419.2% | 689.1% | 1,278.2% | 851.0% | 1,074.0% | 746.1% | 926.4% | 1,023.1% | |
| 47.5% | 55.6% | 48.8% | 52.9% | 87.2% | 202.4% | 1,163.3% | 69.1% | 1,060.6% | 41.1% | 46.4% | 1,022.7% | |
| 0.2% | 0.2% | 0.2% | 0.2% | 36.4% | 120.8% | 1,019.9% | 0.3% | 950.7% | 0.1% | 0.0% | 929.2% | |
| 12.1% | 22.8% | 14.7% | 13.4% | 9.6% | 32.3% | 68.6% | 37.6% | 41.9% | 16.6% | 19.8% | 25.1% | |
| 275.9% | 254.4% | 318.5% | 337.8% | 324.6% | 486.5% | 113.5% | 772.1% | – | 684.7% | 861.2% | – | |
| -229.5% | -213.6% | -274.6% | -297.0% | -319.2% | -589.1% | -1,178.2% | -751.0% | -974.0% | -646.1% | -826.4% | -923.1% | |
| -1,553.5% | -1,256.6% | -1,413.2% | -1,367.9% | -1,344.5% | -2,295.4% | -4,315.5% | -2,684.0% | -3,319.0% | -2,214.6% | -2,776.9% | -3,013.5% | |
| 269.4% | 213.3% | 239.4% | 225.0% | 215.0% | 358.6% | 663.4% | 406.7% | 499.1% | 327.2% | 417.4% | 444.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.